CoverageForm 410-K10-Q8-K13D13G13F

Whalen Matthew Pratt

CIK 0002033867
Director

Filings

3

Latest May 22, 2026

Issuers covered

2

Showing

3 of 3

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Whalen Matthew Pratt. Track record appears once open-market purchases or sales reach the +30 day horizon.

Issuers

Companies where Whalen Matthew Pratt has filed

TickerIssuerFilingsLast filed
TELOTelomir Pharmaceuticals, Inc.2May 22, 2026
MIRAMira Pharmaceuticals, Inc.1Dec 10, 2024

All filings

3 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue